File this under “Nice try, but …
An Ohio congresswoman unsuccessfully attempted to make it possible for the U.S. Department of Health and Human Services to conduct an end run around companies that price drugs — developed with taxpayer dollars — higher than what is charged in seven other high-income countries.
Last week, Rep. Marcy Kaptur (D-Ohio) introduced an amendment to a House appropriations bill that would have authorized HHS to exercise rights in a federal law which, under certain circumstances, would permit a company — other than the licensed patent holder — to make a lower-cost version of a drug.
About the Author Reprints
